Ashwini Gajulapuri

Artiklar

Article: BMC CARDIOVASCULAR DISORDERS. 2019;19(1):34
Serum IL8 is not associated with cardiovascular events but with all-cause mortality
Velasquez IM; Gajulapuri A; Leander K; Berglund A; de Faire U; Gigante B
Article: CARDIOVASCULAR RESEARCH. 2019;115(1):213-221
Interleukin 6 trans-signalling and risk of future cardiovascular events
Ziegler L; Gajulapuri A; Frumento P; Bonomi A; Wallen H; de Faire U; Rose-John S; Gigante B
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy565.p2625
P2625The soluble IL6 receptor and ischemic cerebrovascular disease
Ziegler L; Lundqvist J; Perisic L; Gajulapuri A; Dreij K; Frumento P; Paulsson-Berne G; Wallen H; De Faire U; Hedin U; Gigante B
Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1):ehx504.4159
4159The soluble IL6 receptor as a predictor for early cardiovascular events
Ziegler L; Gajulapuri A; Frumento P; Wallen H; De Faire U; Gigante B
Article: ENVIRONMENTAL HEALTH PERSPECTIVES. 2017;125(6):067007
Exposure to Traffic-Related Air Pollution and Serum Inflammatory Cytokines in Children
Gruzieva O; Merid SK; Gref A; Gajulapuri A; Lemonnier N; Ballereau S; Gigante B; Kere J; Auffray C; Melen E; Pershagen G

Conference publication: EUROPEAN HEART JOURNAL. 2018;39:524-525
The soluble IL6 receptor and ischemic cerebrovascular disease
Ziegler L; Lundqvist J; Perisic L; Gajulapuri A; Dreij K; Frumento P; Paulsson-Berne G; Wallen H; De Faire U; Hedin U; Gigante B
Conference publication: EUROPEAN HEART JOURNAL. 2017;38:857
The soluble IL6 receptor as a predictor for early cardiovascular events
Ziegler L; Gajulapuri A; Frumento P; Wallen H; De Faire U; Gigante B